Endocytic system dysfunction is one of the earliest disturbances that occur in Alzheimer's disease (AD), and may underlie the selective vulnerability of cholinergic basal forebrain (CBF) neurons during the progression of dementia. Herein we report that genes regulating early and late endosomes are selectively upregulated within CBF neurons in mild cognitive impairment (MCI) and AD. Specifically, upregulation of rab4, rab5, rab7, and rab27 was observed in CBF neurons microdissected from postmortem brains of individuals with MCI and AD compared to agematched control subjects with no cognitive impairment (NCI). Upregulated expression of rab4, rab5, rab7, and rab27 correlated with antemortem measures of cognitive decline in individuals with MCI and AD. qPCR validated upregulation of these select rab GTPases within microdissected samples of the basal forebrain. Moreover, quantitative immunoblot analysis demonstrated upregulation of rab5 protein expression in the basal forebrain of subjects with MCI and AD. The elevation of rab4, rab5, and rab7 expression is consistent with our recent observations in CA1 pyramidal neurons in MCI and AD. These findings provide further support that endosomal pathology accelerates endocytosis and endosome recycling, which may promote aberrant endosomal signaling and neurodegeneration throughout the progression of AD.
Introduction
Degeneration of cholinergic basal forebrain (CBF) neurons within the nucleus basalis (NB) is a pathological hallmark of Alzheimer's disease (AD) in concert with amyloid deposition, neurofibrillary tangle (NFT) accumulation, and synaptic loss. Notably, CBF neurons are selectively vulnerable to neurodegeneration during the early stages of AD (Cuello et al., 2010; Mufson et al., 2003 Mufson et al., , 2007a Whitehouse et al., 1982) . Mechanisms underlying the degeneration of the cholinergic neurons within the NB region of the CBF are not well understood. This data is critical for the development of rational therapies for age-related dementing illnesses, including mild cognitive impairment (MCI) and AD.
The endosomal pathway performs a multiplicity of integral functions in neurons including internalizing nutrients and growth factors, recycling receptors, and signaling information to appropriate intracellular pathways (Bishop, 2003; Cataldo et al., 1996; Nixon and Cataldo, 1995) . A group of small ras-related GTPase (rab) proteins coordinate trafficking of vesicles from early to late endosomes and other organelles along endosomal-lysosomal pathways (Ng and Tang, 2008; Novick and Brennwald, 1993; Seachrist and Ferguson, 2003; Spang, 2004; Zerial and Stenmark, 1993) . Early endosomes receive their contents through endocytosis and target cargoes for vesicular transport via late endosomes to lysosomes, deliver specific cargoes to the Golgi via the retromer, and/or recycle elements to the plasma membrane (Bonanomi et al., 2006; Bronfman et al., 2007) . Late endosomes obtain degradative enzymes, including acid hydrolases such as cathepsins, from the trans-Golgi network or by fusion with lysosomal compartments (Bright et al., 2005; Cowles et al., 1997) . Endosomes play a crucial role in neuronal development and synaptic transmission (Bronfman et al., 2007; Ibanez, 2007; Salehi et al., 2006; Wang et al., 2007) . Moreover, signaling endosomes contain rab GTPases and neurotrophin receptor signaling complexes. For example, the early endosome effector rab5 and late endosome constituent rab7 have been shown in cellular models to regulate nerve growth factor (NGF) signaling (Deinhardt et al., 2006; Liu et al., 2007; Saxena et al., 2005; Valdez et al., 2007) . Further, our group has demonstrated that upregulation of rab5 expression downregulates the brain-derived neurotrophic receptor (BDNF) receptor TrkB (Ginsberg et al., 2010a) .
Dysfunction of the endosomal system is one of the earliest pathologies observed in the AD brain, as early endosomes in vulnerable forebrain neurons are significantly enlarged compared to control brains (Cataldo et al., 1997 Nixon et al., 2001) . Endosomal alterations precede manifestations of clinical symptoms of AD, intracellular NFT formation, cerebral and vascular amyloid deposition, and are highly selective for AD Nixon and Cataldo, 2006; Nixon et al., 2001) . In addition, proteins involved in the regulation of endocytosis and early endosomal fusion, including the rab GTPases rab4 and rab5 are increased in expression and altered in location in the AD brain as well as in animal and cellular models of this disease, reflecting an over activation of endocytosis (Grbovic et al., 2003; Mathews et al., 2002; Nixon, 2004) . Recently, we observed a selective upregulation of genes regulating early endosomes (rab4 and rab5), late endosomes (rab7), and trafficking compartments (rab24), among others within CA1 hippocampal pyramidal neurons harvested postmortem from subjects with an antemortem clinical diagnosis of MCI and AD (Ginsberg et al., 2010a) . Upregulation of these rab GTPase genes correlate with cognitive decline during AD progression, and hippocampal qPCR and immunoblot analyses confirmed increased levels of these transcripts and their respective encoded proteins, although causality cannot be determined in postmortem human tissues (Ginsberg et al., 2010a (Ginsberg et al., , 2010b . At the molecular and cellular level, endosomal pathway gene dysregulation likely affects survival and maintenance of various forebrain projection systems including the basocortical cholinergic system, which depend upon retrograde trafficking of members of the NGF family of neurotrophins and their receptors and play a key role in the pathogenic and clinical progression of AD (Bronfman et al., 2007; Mufson et al., 2007a Mufson et al., , 2007b . Thus, the regulation of neurotrophin signaling in the forebrain is likely to be dependent upon a multiplicity of factors including specific rab GTPases, among other potential regulators (Ginsberg et al., 2010a) . In this regard, single population expression profiling studies from our group demonstrated early down regulation of the NGF, BDNF, and NT3 receptors TrkA, TrkB, TrkC, respectively, but not the pan-neurotrophin receptor p75 NTR within NB neurons during the progression of AD (Ginsberg et al., 2006b (Ginsberg et al., , 2006c but whether these neurons also display alterations in endosomal-lysosomal gene expression is unknown. Previous studies report an upregulation of select rab GTPases localized to early endosomal, late endosomal, and trafficking compartments within CA1 neurons (Ginsberg et al., 2010a) as well as rab5 and rab7 protein level upregulation in the hippocampus (Ginsberg et al., 2010b) , assessment of rab GTPase expression levels within CBF neurons along with coordinated encoded protein expression level assessment is warranted.
As progressive late-onset neurodegenerative disorders such as AD differentially affect neurons throughout the forebrain, assessment of individual populations of vulnerable neurons is highly desirable, as this approach obviates concerns of heterogeneous expression profiles derived from admixed neuronal and non-neuronal cell types (Ginsberg, 2008; Ginsberg et al., 2011; Ginsberg and Mirnics, 2006) . Herein, select endosomal markers were assessed within homogeneous populations of NB CBF neurons harvested from subjects who died with a clinical diagnosis of no cognitive impairment (NCI), MCI, or AD using laser capture microdissection (LCM) and custom-designed microarray analysis along with qPCR and immunoblot validation of select genes that were differentially regulated on the microarray platform.
Materials and Methods

Brain tissue
This study was performed under the auspices of Institutional Review Board (IRB) guidelines administrated by the Rush University Medical Center and the Nathan Kline Institute/New York University Langone Medical Center. Clinical and neuropsychological criteria for the Religious Orders Study cohort have been published previously Mufson et al., 2000 Mufson et al., , 2002 . Subjects deemed to be devoid of any comorbid conditions contributing to cognitive impairment were entered into the Religious Orders Study. Antemortem cognitive testing, including the Mini-Mental State Exam (MMSE) and a global cognitive score (GCS) were available within the last year of death. The GCS consists of a battery of 19 neuropsychological tests, providing a composite score for each subject in addition to the individual scores on the respective tests (Arvanitakis et al., 2008; Bennett et al., 2002) . A board-certified neurologist designated a clinical diagnosis of NCI {n=11; mean age ± standard deviation (SD) = 81.0 ± 9.6 years}, MCI (n = 10; 81.9 ± 4.3 years), and mild/ moderate AD (n = 9; 86.6 ± 4.8 years) for each Religious Orders Study participant (Table I) . MCI subjects were defined as individuals with impaired cognitive testing without frank dementia (DeKosky et al., 2002; Mufson et al., 2000) , consistent with the clinical classification of MCI adopted by independent research groups (Petersen and Negash, 2008; Reisberg et al., 2008; Winblad et al., 2004) .
Tissue blocks containing the substantia innominata which includes the cholinergic neurons of the NB (Mufson et al., , 2003 were obtained at autopsy and immersion-fixed in 4% paraformaldehyde in 0.1 M phosphate buffer, pH 7.2 for 24 hours at 4 °C, paraffin embedded, and sectioned at 6 μm thickness. Adjacent tissue slabs were also snap-frozen in liquid nitrogen for qPCR and immunoblotting studies. A neuropathological diagnosis was made independent of the clinical diagnosis. Neuropathological designations were based on NIA-Reagan, CERAD, and Braak staging criteria (Braak and Braak, 1991; Hyman and Trojanowski, 1997; Mirra et al., 1991) . ApoE genotype and amyloid burden were assessed as described previously (Arvanitakis et al., 2008; Bennett et al., 2004; Braak and Braak, 1991; Counts et al., 2007; Mufson et al., 2000) .
Tissue preparation for microarray analysis
Acridine orange histofluorescence (Ginsberg et al., 1997 (Ginsberg et al., , 1998 Mufson et al., 2002) and bioanalysis (2100, Agilent Biotechnologies, Palo Alto, CA) (Ginsberg et al., 2006a (Ginsberg et al., , 2006c Ginsberg and Mirnics, 2006) were performed on each brain to ensure the presence of high quality RNA. All of the solutions were made with 18.2 mega Ohm RNase-free water (Nanopure Diamond, Barnstead, Dubuque, IA) and RNase-free precautions were used throughout the experimental procedures.
Immunocytochemistry to identify CBF neurons for custom-designed microarray analysis was performed as described previously (Counts et al., 2007 (Counts et al., , 2009 Ginsberg et al., 2006a Ginsberg et al., , 2006c . Tissue sections were processed for immunocytochemistry using a monoclonal antibody raised against human p75 NTR (Counts et al., 2004; Mufson et al., 1989a Mufson et al., , 2002 Schatteman et al., 1988) . p75 NTR colocalizes with approximately 95% of all CBF neurons within the human NB (Mufson et al., 1989a (Mufson et al., , 1989b . CBF neurons selected for microaspiration were localized to the anterior subfields of the NB extending from the decussation of the anterior commissure to its emergence at level of the amygdalar complex (Mufson et al., 1989b . Deparaffinized tissue sections were blocked in a 0.1 M Tris (pH 7.6) solution containing 2% donor horse serum (DHS; Sigma, St. Louis, MO) and 0.01% Triton X-100 for 1 hour and then incubated with the primary antibody (Neomarkers, Fremont, CA; 1:20,000 dilution) in a 0.1 M Tris/2% DHS solution overnight at 4 °C in a humidified chamber. Sections were processed with the ABC kit (Vector Labs, Burlingame, CA) and developed with 0.05% diaminobenzidine (Sigma), 0.03% hydrogen peroxide, and 0.01 M imidazole in Tris buffer for 10 minutes (Counts et al., 2009; Ginsberg et al., 2006a Ginsberg et al., , 2006c Ginsberg et al., , 2010a . Tissue sections were not coverslipped or counterstained and maintained in RNase-free 0.1 M Tris for LCM.
LCM and Terminal Continuation (TC) RNA amplification
LCM and TC RNA amplification procedures have been described in detail (Alldred et al., 2008 (Alldred et al., , 2009 Che and Ginsberg, 2004; Ginsberg, 2005 Ginsberg, , 2008 Ginsberg et al., 2010a) . CBF neurons from the NB were microaspirated via LCM (Arcturus PixCell IIe, Applied Biosystems, Foster City, CA) as described previously (Counts et al., , 2009 Ginsberg et al., 2006b Ginsberg et al., , 2010a . Approximately 25 cells were captured per reaction for population cell analysis. A total of 3-8 reactions (containing 50 LCM-captured CBF neurons each) were performed per human brain. Linearity and reproducibility of the TC RNA amplification procedure has been published previously, including the use of CBF neurons as input sources of RNA (Alldred et al., 2008 (Alldred et al., , 2009 Che and Ginsberg, 2004; Ginsberg, 2008) . The TC RNA amplification protocol is available at http://cdr.rfmh.org/pages/ginsberglabpage.html. LCM-captured CBF neurons were homogenized in 500 μl of Trizol reagent (Invitrogen), chloroform extracted, and isopropanol precipitated (Alldred et al., 2009) . RNAs were reverse transcribed in a solution containing a poly d(T) primer (100 ng/μl) and TC primer (100 ng/μl) in 1X first strand buffer (Invitrogen), 2 μg of linear acrylamide (Applied Biosystems), 10 mM dNTPs, 100 μM dithiothreitol (DTT), 20 U of SuperRNase Inhibitor (Applied Biosystems) and 200 U of reverse transcriptase (Superscript III, Invitrogen). Single stranded cDNAs were digested and then placed in a thermal cycler in a solution consisting of 10 mM Tris (pH 8.3), 50 mM KCl, 1.5 mM MgCl 2 , and 10 U RNase H (Invitrogen) in a final volume of 100 μl. The thermal cycler program was set as follows: RNase H digestion at 37 °C, 30 minutes; denaturation at 95 °C, 3 minutes; and primer re-annealing at 60 °C, 5 minutes. Samples were purified by column filtration (Montage, Millipore, Billerica, MA). Hybridization probes were synthesized by in vitro transcription using 33 P incorporation in 40 mM Tris (pH 7.5), 6 mM MgCl 2 , 10 mM NaCl, 2 mM spermidine, 10 mM DTT, 2.5 mM ATP, GTP and CTP, 100 μM of cold UTP, 20 U of RNase inhibitor, 2 KU of T7 RNA polymerase (Epicentre, Madison, WI), and 120 μCi of 33 P-UTP (Perkin-Elmer, Boston, MA) (Alldred et al., 2009; Ginsberg, 2008) . The reaction was performed at 37 °C for 4 hours. Radiolabeled TC RNA probes were hybridized to custom-designed cDNA arrays without further purification.
Custom-designed array platforms and hybridization
Array platforms consisted of 1 μg of linearized cDNA purified from plasmid preparations adhered to high-density nitrocellulose (Hybond XL, GE Healthcare, Piscataway, NJ). Each cDNA and/or expressed sequence-tagged cDNA (EST) was verified by restriction digestion and sequence analysis. Human and select mouse clones were employed on the customdesigned array. Notably, all of the rab GTPases and related endosomal-lysosomalautophagic genes were derived from human sequences. Approximately 576 cDNAs/ESTs were utilized on the current array platform. The majority of genes are represented by one transcript on the array platform.
Arrays were prehybridized (2 hours) and hybridized (12 hours) in a solution consisting of 6X saline-sodium phosphate-ethylenediaminetetraacetic acid (SSPE), 5X Denhardt's solution, 50% formamide, 0.1% sodium dodecyl sulfate (SDS), and denatured salmon sperm DNA (200 μg/ml) at 42 °C in a rotisserie oven (Ginsberg, 2005 (Ginsberg, , 2008 . Following hybridization, arrays were washed sequentially in 2X SSC/0.1% SDS, 1X SSC/0.1% SDS and 0.5X SSC/0.1% SDS for 15 min each at 37 °C and placed in a phosphor screen for 24 hours. Arrays were developed on a phosphor imager (GE Healthcare). All array images were adjusted to the same brightness and contrast levels for data acquisition and analysis.
Statistical analysis for the microarray study
Procedures for custom-designed microarray analysis have been described in detail (Alldred et al., 2008 (Alldred et al., , 2009 Ginsberg, 2008; Ginsberg et al., 2006b Ginsberg et al., , 2006c Ginsberg et al., , 2010a Ginsberg and Mirnics, 2006) . Briefly, expression of TC amplified RNA bound to each linearized cDNA minus background was expressed as a ratio of the total hybridization signal intensity of the array. This global normalization approach does not allow the absolute quantitation of mRNA levels. However, an expression profile of relative changes in mRNA levels was generated (Eberwine et al., 2001; Ginsberg, 2005 Ginsberg, , 2008 . Clinical and demographic characteristics were compared among clinical diagnostic groups by one-way analysis of variance (ANOVA) or Fisher's exact test and neuropathologic classifications were compared by Kruskal-Wallis test. Bonferroni correction was employed for multiple comparisons. Associations between gene expression levels and case characteristics including diagnostic groups, demographic, clinical, and neuropathological variables was evaluated via mixed models repeated measures analyses with random intercept, fixed effect covariate, equal variance assumption, Kenward-Roger denominator degrees of freedom, and unstructured covariance structure (SAS Institute Inc, 2009 ). In cases where at least one variance component was estimated to be zero, analyses were performed with the term for random intercept removed from the model. For graphical presentations, the mean expression level of each case was plotted. The level of statistical significance was set at 0.01 (two-sided) to account for the large number of analyses performed. qPCR qPCR was performed on frozen micropunches of the basal forebrain containing the NB from NCI (n= 11), MCI (n= 8), and mild/moderate and severe AD (n= 8) Religious Orders Study cases. Five of these cases were also included in the microarray experiment. See Supplemental Table I for demographic information and neuropathological assessment of the cases used for qPCR. Taqman (Applied Biosystems) qPCR primers were employed for the following genes: rab4 (Hs01106488_m1), rab5 (Hs00991293_g1), rab7 (Hs01115139_m1), rab24 (Hs01585713_g1), rab27 (Hs00608302_m1), and the housekeeping gene Gapdh (Hs02758991_g1). Assays were performed on a real-time PCR cycler (7900HT, Applied Biosystems) in 96-well optical plates with caps (Alldred et al., 2008 (Alldred et al., , 2009 Devi et al., 2010; Kaur et al., 2010) . The ddCT method was employed to determine relative gene level differences with Gapdh qPCR products used as a control (ABI, 2004; Alldred et al., 2009; Devi et al., 2010; Kaur et al., 2010) . qPCR assessments were run in triplicate for each case. Variance component analyses demonstrated that the within-case variability was sufficiently small. Therefore, the triplicate average was computed for each case and used in subsequent analyses. Alterations in PCR product synthesis were compared across diagnostic groups by Kruskal-Wallis test, with Bonferroni correction for post-hoc comparisons. Associations between qPCR expression levels and cognitive measures or neuropathological criteria were assessed by Spearman rank correlation or Wilcoxon rank-sum test. The level of statistical significance was set at 0.05 (two-sided).
Immunoblot analysis
Frozen basal forebrain samples microdissected from NCI (n= 18), MCI (n= 10), and mild/ moderate and severe AD (n= 19) brains were obtained from four brain banks (see Supplemental Table II for case demographics and neuropathological characterization). The 5 Religious Orders Study cases with tissue available for both the microarray and qPCR experiments were also included in the immunoblot analysis. Samples were homogenized in a 20 mM Tris-HCl (pH 7.4) buffer containing 10% (w/v) sucrose, 1 mM ethylenediaminetetraacetic acid (EDTA), 5 mM ethylene glycol-bis (ß-aminoethylether)-N, N, N', N'-tetra-acetic acid (EGTA), 2 mg/ml of the following: (aprotinin, leupeptin, and chymostatin), 1 mg/ml of the following: {pepstatin A, antipain, benzamidine, and phenylmethylsulfonyl fluoride (PMSF)}, 100 μg/ml of the following: {soybean trypsin inhibitor, Na-p-tosyl-L-lysine chloromethyl ketone (TLCK), and N-tosyl-L-phenylalanine chloromethyl ketone (TPCK)}, 1 mM of the following: (sodium fluoride and sodium orthovanadate) and centrifuged as described previously (Counts et al., 2004; Ginsberg et al., 2010a Ginsberg et al., , 2010b . All protease inhibitors were purchased from Sigma (St. Louis, MO). Homogenates (10 μg) were subjected to sodium dodecyl sulfate-polyacrylamide gel electrophoresis (SDS-PAGE; 4-15% gradient acrylamide gels; Bio-Rad, Hercules, CA), and transferred to nitrocellulose by electroblotting (Mini Transblot, Bio-Rad). Nitrocellulose membranes were placed in blocking buffer (LiCor, Lincoln, NE) for 1 hour at 4 °C prior to being incubated with antibodies directed against rab5 (rab5A; rabbit polyclonal sc-309; Santa Cruz Biotechnology, Santa Cruz, CA; 1:1,000 dilution), rab7 (rabbit polyclonal sc-10767; Santa Cruz Biotechnology 1:1,000 dilution), or ß-tubulin (TUBB; monoclonal antibody; Sigma, 1:1,000 dilution) in blocking buffer overnight at 4 °C. Membranes were developed using affinity-purified secondary antibodies conjugated to IRDye 800 (Rockland, Gilbertsville, PA), visualized using an infrared detection system (Odyssey, LiCor), and immunoblots quantified by densitometric software supplied by the manufacturer. rab5-immunoreactive and rab7-immunoreactive bands were normalized to TUBB immunoreactivity. Differences in immunoreactive band intensity were compared across diagnostic groups by Kruskal-Wallis test, with Bonferroni correction for post-hoc comparisons. Associations between protein levels and clinical, demographic, and neuropathological variables were assessed by Spearman rank correlation or Wilcoxon ranksum test. The level of statistical significance was set at 0.05 (two-sided).
Results
Clinical and neuropathological characteristics
In all three experiments (microarray, qPCR, and immunoblot analysis), age, gender, educational level, and postmortem interval (PMI) were comparable across the three clinical diagnostic groups (Table I and Supplemental Tables I and II) . Distribution of Braak scores was significantly different across clinical conditions, with NCI having lower Braak scores than AD and the Braak scores of MCI between those of NCI and AD (Table I and  Supplemental Tables I and II) . NIA-Reagan diagnosis and CERAD diagnosis, which were available for the microarray and qPCR cases, differentiated NCI from AD (see Table I and Supplemental Table I ).
Microarray analysis of select rab GTPases in CBF neurons
Datasets were generated by expression profiling 174 NB LCM population cell captures (with a median of 5 and a range of 3-11 cells per case) via custom-designed microarray analysis. Results identified differential regulation of several rab GTPases, including significant up regulation of early endosome effectors rab4 (p < 0.0008; AD>NCI & MCI) and rab5 (p < 0.0001; AD & MCI>NCI), late endosome constituent rab7 (p < 0.0002; AD & MCI>NCI), and the exocytic secretion pathway molecule rab27 (p < 0.002; AD>NCI) ( Fig.  1 and Table II) . Alterations in rab5 and rab7 expression were considered early changes, as upregulation was observed in MCI and AD, rab27 upregulation in MCI was considered intermediate between NCI and AD, whereas upregulation of rab4 appeared as a later alteration, since significant changes were found in AD, but not MCI, consisent with our previous observations in CA1 pyramidal neurons (Ginsberg et al., 2010a) . Despite the suggestion of a trend (e.g., for downregulation of the synaptic-related marker rab3), no statistically significant differential regulation was observed for rab1, rab2, rab3, rab6, rab10, or rab24 (Table II) . Moreover, expression profiling of select rab GTPases in postmortem NB neurons correlated with antemortem cognitive measures. Strong negative associations were found between GCS performance and rab4 (p < 0.02), rab5 (p < 0.004), rab7 (p < 0.006), and rab27 (p < 0.004) NB neuron expression levels (Fig. 2) . Similar associations were also observed between MMSE and these CBF neuron expression levels (data not shown). Higher Braak scores were associated with upregulation of rab5 (p < 0.01), rab7 (p < 0.008), and rab27 (p < 0.04) in CBF neurons.
qPCR validation of microarray data
Select rab GTPase gene expression levels were evaluated via qPCR using micropunches of frozen basal forebrain obtained from NCI, MCI, and AD cases. qPCR analysis independently validated the microarray findings, including upregulation of rab4, rab5, rab7, and rab27 and no changes in rab24 expression (Table III) . Similar to the microarray observations, correlation of basal forebrain qPCR product levels with antemortem cognitive measures and neuropathological criteria indicated significant negative association between GCS performance with rab4 (p < 0.0006), rab5 (p < 0.0001), rab7 (p < 0.0001), and rab27 (p < 0.04) basal forebrain expression levels. Similar correlations were observed between MMSE scores and rab4, rab5, rab7, and rab27 expression levels. Basal forebrain rab GTPase upregulation also correlated with Braak scores, NIA-Reagan diagnosis, and CERAD diagnosis for rab4 (Braak, p < 0.02 ; NIA-Reagan, p < 0.005; CERAD, p < 0.03), rab5 (Braak, p < 0.0005; NIA-Reagan, p < 0.002; CERAD, p < 0.01), rab7 (Braak, p < 0.002; NIA-Reagan, p < 0.0004; CERAD, p < 0.03), and rab27 (Braak, p < 0.002; NIAReagan, p < 0.002; CERAD, p < 0.02).
Immunoblot assessment of rab5 and rab7 in the basal forebrain
Immunoblot analysis using basal forebrain homogenates identified an ~27 kDa band with the rab5 antibody and an ~25 kDa band with the rab7 antibody. Quantitative analysis demonstrated a significant upregulation of rab5 (p < 0.02; AD & MCI>NCI) indicative of an early alteration, whereas comparison of rab7 expression among clinical diagnostic groups did not reach statistical significance (Table IV) . Upregulation of basal forebrain rab5 expression also correlated with Braak staging (p < 0.002).
Discussion
An overall goal of our expression profiling studies is to identify mechanisms that underlie selective vulnerability of specific neurons and fucntional circuits during the progression of AD. In the present study we applied this approach at the level of homogeneous neuronal populations to evaluate vulnerable cholinergic neurons within the NB subfield of the CBF. Simultaneous quantitative assessment of multiple rab GTPase mRNAs by LCM, TC RNA amplification, and custom-designed microarray analysis combined with qPCR and immunoblot validation strategies provides a paradigm whereby CBF neurons can be differentiated from adjacent neuronal and non-neuronal populations (Che and Ginsberg, 2004; Ginsberg, 2008; Ginsberg et al., 2006c; Mufson et al., 2008) . Importantly, the experimental design enables postmortem quantitative analyses of vulnerable CBF neurons in subjects at different stages of clinical impairment and facilitates comparisons with antemortem cognitive measures from the same subjects (Counts et al., 2007; Galvin and Ginsberg, 2005; Ginsberg et al., 2006c Ginsberg et al., , 2010a . Results indicate endosomal dysfunction occurs within the cholinergic neurons of the NB during prodromal AD. Expression profiling revealed significant upregulation of early endosome effector genes including rab4 and rab5, the late endosome gene rab7, and exocytic pathway gene rab27 as AD progresses. Importantly, upregulation of these select rab GTPases correlated with cognitive decline and neuropathological criteria for AD. These findings are similar to those found within CA1 pyramidal neurons,where an upregulation of rab4, rab5, and rab7 were observed (Ginsberg et al., 2010a) , consistent with the present report. Interestingly, the trafficking marker rab24 was upregulated in CA1 pyramidal neurons, whereas rab27 was not differentially regulated (Ginsberg et al., 2010a) , which may reflect the intrinsic properties of these two different cell types.
The present results are consistent with a growing body of literature in human postmortem material and in animal and cellular models of AD and Down's syndrome (DS) that indicate over activation of the endosomal pathway occurs early in the progression of the disease process. Current findings confirm and extend previous morphological, molecular, and cellular datasets demonstrating enlarged endosomes and upregulation of select rab GTPases in AD (Cataldo et al., 1996 (Cataldo et al., , 2008 Ginsberg et al., 2010a; Grbovic et al., 2003; Nixon and Cataldo, 2006) . Specifically, overexpression of rab5 causes enlarged endosomes, one of the earliest pathological alterations observed in AD, and rab5 upregulation is found in vulnerable hippocampal and basal forebrain regions, but not in the relatively spared striatum and cerebellum in MCI and AD (Cataldo et al., , 2008 Ginsberg et al., 2010b) . The present novel finding of rab27 upregulation is consistent with exosome secretion abnormalities in AD (Ghidoni et al., 2009; Gomi et al., 2007; Ostrowski et al., 2010) , and may point to a link in defective TrkB trafficking through interactions with rab27 on signaling endosomes (Arimura et al., 2009 ).
Without proper expression and maintenance of neurotrophin receptors, principally TrkA and the pan-neurotrophin receptor p75 NTR within CBF neurons, cholinotrophic forebrain circuits critically important for mnemonic and executive function are at risk for neurodegeneration (Boissiere et al., 1997; Chu et al., 2001; Ginsberg et al., 2006c; Mufson et al., 2007b Mufson et al., , 2008 .
The regulation of neurotrophin signaling in the forebrain is likely to be dependent upon a multiplicity of factors including specific rab GTPases. Indeed, our previous single cell research has demonstrated early down regulation of TrkA, TrkB, TrkC, but not p75 NTR within CBF neurons of the NB during the progression of AD (Ginsberg et al., 2006b (Ginsberg et al., , 2006c . We cannot exclude the possibility that other factors, such as gender, immunological responses, epigenetic alterations, and environmental exposures (Chouliaras et al., 2010; Coppede and Migliore, 2010; Counts et al., 2011; Licastro and Chiappelli, 2003) , as well as additional classes of transcripts and their encoded proteins are involved in neurodegenerative programs within vulnerable populations, such as CBF neurons, within MCI and AD brains including glutamate receptor subunits, synaptic-related markers, energy and metabolism related markers, and apoptotic signaling genes, among others (Blalock et al., 2004; Colangelo et al., 2002; Liang et al., 2007 Liang et al., , 2008 . Notwithstanding these caveats, interrelationships between retrograde endosomal trafficking of neurotrophin/neurotrophin receptor complexes are well documented, particularly within the basal forebrain cholinergic neuronal system with NGF and BDNF binding to, and trafficking with TrkA, TrkB, and p75 NTR (Arimura et al., 2009; Bronfman et al., 2007; Howe and Mobley, 2004; Valdez et al., 2007) . Interestingly, in vitro studies indicate that rab5 overexpression downregulates TrkB (Ginsberg et al., 2010a) . This observation together with our findings of rab5 gene and protein upregulation in both CA1 pyramidal and CBF neurons suggest a mechanistic interaction associated with neuronal vulnerability. The endosomal system is also perturbed in relevant animal models, including the Ts65Dn mouse model of DS and AD, with amyloid-beta precursor protein (APP) being required for the manifestation of the early endosome enlargement phenotype Salehi et al., 2006) . These finding suggest an interaction between App gene dosage, APP processing, and APP metabolites of this regulatory circuit with the endosomal system. rab GTPase-mediated regulation of endocytosis is critical for synaptic plasticity associated with learning and memory (Ng and Tang, 2008; Nixon, 2004) , as well as with cellular degradative pathways shown to be dysfunctional in the AD brain . Importantly, rab5, rab7, and rab27 regulate endocytic sorting within axonal retrograde transport pathways (Arimura et al., 2009; Deinhardt et al., 2006) . The present expression profiling results within homogeneous populations of NB CBF neurons indicate the importance of evaluating rab GTPases and other endosomal-lysosomalautophagic markers within vulnerable cell types in MCI and AD. Within the context of our ongoing profiling studies of NB CBF neurons across different stages of cognitive impairment (NCI, MCI, and AD), upregulation of select rab GTPases is found along with dysregulation of several other relevant markers, including upregulation of α7 nicotinic acetylcholine receptor (CHRNA7) and matrix metalloproteinase 9 (MMP-9) expression (Bruno et al., 2009; Counts et al., 2007) , an increase in the ratio of proNGF to the mature NGF peptide (Mufson et al., 2007b; Peng et al., 2004) , and galanin fiber hyperinnervation in CBF neurons (Counts et al., 2006 (Counts et al., , 2009 (Fig. 3) . By contrast, downregulation of TrkA, TrkB, TrkC, and BDNF (both proBDNF and the mature peptide) is also observed within NB CBF neurons (Ginsberg et al., 2006b (Ginsberg et al., , 2006c Peng et al., 2005) , along with a shift in the 3-repeat tau/4-repeat tau ratio (Ginsberg et al., 2006a) , providing a dynamic regulation of genes and encoded proteins that may be a fingerprint of selective vulnerability (Fig. 3) . Also, several genes and encoded proteins that are relevant to the cholinergic phenotype of CBF neurons do not appear to be altered in AD (with the possible exception of end-stage disease), including p75 NTR , sortilin, and choline acetyltransferase (ChAT) (Ginsberg et al., 2006b (Ginsberg et al., , 2006c Mufson et al., 2002 Mufson et al., , 2010 , although potential gender differences within p75 NTR expression are now being recognized (Counts et al., 2011) . We conclude that over activation of select early and late endocytic as well as exocytic rab GTPases contribute to CBF neurodegeneration, in part, by impairing neurotrophin receptor signaling and that these genes are early molecular markers for the development of MCI and AD.
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Refer to Web version on PubMed Central for supplementary material. Differential regulation of rab GTPases during the progression of AD. Box and whisker plots indicating log-transformed gene expression levels of select rab GTPases. Upregulation of rab5 and rab7 was found in MCI and AD (asterisks) and is considered an early change. Upregulation of rab4 was seen in AD (asterisk) and is considered a later change. rab27 upregulation in MCI (double asterisk) was considered intermediate between NCI and AD (asterisk). Association between select rab GTPase gene expression levels within CBF neurons and antemortem cognitive measures in the same subjects. Scatterplots illustrate the association between gene expression levels and GCS for cases classified as AD (red circles), MCI (blue triangles), and NCI (green squares). Strong negative associations were observed between rab4 (p < 0.02), rab5 (p < 0.004), rab7 (p < 0.006), and rab27 (p < 0.004) gene expression and GCS performance. No significant associations were observed between rab10 and rab24 expression and GCS. Schematic illustrating the balance between specific genes and encoded proteins that are altered in vulnerable CBF neurons during the progression of AD. Specific elements that have been found to be upregulated (white), downregulated (black), and not significantly altered (yellow) are depicted which may contribute to the selective vulnerability of NB neurons. Adapted from . Table I Microarray analysis: clinical, demographic, and neuropathological characteristics by diagnosis category Table II rab GTPase expression levels (via microarray analysis) by disease category (mean ± SEM) Table III rab GTPase expression levels via qPCR analysis by disease category (mean ± SD) 
